Commentary: Healthcare Lived Experiences of African, Caribbean, and Black Individuals in Alberta living with HIV/AIDS

Joseph Osuji

Professor and Director, School of Nursing and Midwifery, Mount Royal University, Calgary, Canada


Despite biomedical advances that have made HIV a manageable chronic illness and the outcry over increasing access to care for marginalized groups, African, Caribbean, and Black (ACB) communities in Canada still experience disproportionate HIV rates and worse health outcomes related to HIV. A recent phenomenological study by Osuji, Domingo, and Olokude (2025) examines the lived experiences of ACB individuals in Alberta as they navigate HIV care.

Objective: This commentary critically analyses the findings of this study through the lenses of Critical Race Theory, intersectionality, public health policy, and health equity.

Discussion: This study's themes—health literacy and empowerment, non-belonging and invisibility, barriers to adherence, and psychosocial life impact—highlight how structural racism, stigma, and systemic neglect influence HIV care for ACB populations in Alberta. This commentary asserts that these inequities are not incidental but are deeply embedded in healthcare systems and broader societal structures. The invisibility of ACB people within HIV policy and data exemplifies structural racism, leading to poorer health outcomes and wider failures in public health.

Implications: Public health policies and practices must prioritize culturally responsive care, community-based interventions, disaggregated data collection, psychosocial support, and reforms to address the social determinants of health. Without intentional action, Canada will not achieve its HIV elimination targets or uphold its commitment to equity.

Conclusion: Ending HIV requires more than biomedical solutions. It involves dismantling systemic racism, fostering a sense of belonging, and creating inclusive systems where Black lives are visible, valued, and supported.


Despite medical advances that have transformed HIV from a fatal disease into a manageable chronic condition, the epidemic still disproportionately impacts ACB communities in Canada and around the world1,2. Osuji et al.'s (2025) phenomenological study provides a vital perspective on the lived experiences of ACB individuals in Alberta navigating HIV care. Their findings—organized around themes of health literacy and empowerment, non-belonging and invisibility, barriers to adherence, and psychosocial health impact—highlight a troubling reality: stigma, discrimination, and systemic anti-Black racism remain significant barriers to equitable care. This reveals that anti-Black racism in HIV care persists, underscoring an ongoing public health crisis of belonging.

This commentary critically evaluates their findings through the lenses of public health, Critical Race Theory (CRT)3, and intersectionality4. The main argument is that the invisibility of ACB people within Canadian HIV policy and practice exemplifies structural racism, which creates barriers not only to care but also to belonging. Moreover, these inequities are not solely issues for ACB communities but for the entire population because they resonate throughout society, undermine public health objectives, perpetuate health disparities, and weaken collective resilience.

Canada's HIV response has made significant progress towards the UNAIDS 90-90-90 targets, with viral suppression rates surpassing global averages5. However, these achievements conceal profound inequalities upon closer examination. National surveillance data reveal the disproportionate impact of HIV on ACB Canadians. Although Black people constitute about 5% of the population, they account for 25% of new HIV infections nationwide1, and nearly half of all new cases in 2017 involved ACB individuals2. This unequal burden is rooted not in biological vulnerability but in structural disparities driven by the cumulative effects of racism, migration stress, poverty, and stigma6,7. The study based in Alberta underscores how systemic racism manifests at both micro-level—during patient-provider interactions—and macro-level—through access to health services.

Participants reported delays in treatment, long wait times, insensitive communication, and experiences of exclusion8. These are not isolated stories and reflect structural realities consistent with other Canadian research on medical mistrust among ACB communities in Canada9,10. Such mistrust is not unfounded; it results from a healthcare system that has historically and persistently marginalized Black lives11.

Critical Race Theory (CRT) provides a robust framework for understanding these findings. It explains that racism is not just individual bias but is embedded in laws, institutions, and discourses12,13. The invisibility experienced by participants reflects structural and systemic processes that render Black suffering unseen within Canadian healthcare narratives. Intersectionality further clarifies how racial inequalities become more severe when they intersect with gender, sexuality, class, and immigration status14,15. For example, Black women living with HIV often face not only racial discrimination but also misogyny, a form of racism and sexism that targets Black women explicitly6,15. This intensifies stigma, hinders disclosure, and worsens vulnerabilities at the intersection of racialization16. Therefore, HIV care for Black individuals must be viewed within the broader systems of oppression.

Another notable contribution of Osuji et al.'s8 study is the introduction of the concepts of “non-belonging and invisibility.” Belonging is not a privilege but a crucial element in health17. When individuals feel they do not belong in healthcare settings or within their communities, they often disengage, miss appointments, and delay starting treatment. Conversely, when patients feel seen, valued, and included, their adherence to care improves, and psychosocial outcomes are significantly enhanced18.

The feelings of exclusion and othering within the ACB community in HIV care reflect wider racialized barriers to participation in Canadian public life. ACB Canadians have historically been invisible in national health data, policies, and interventions19,20. Without disaggregating HIV-related data by ethnicity and race, disparities remain hidden, perpetuating structural neglect21. This results not only in poorer health outcomes for Black individuals but also in a weakened public health system that fails to uphold its commitment to equity.

Participants in the Alberta study described how an HIV diagnosis motivated their pursuit of knowledge, leading to increased health literacy and a sense of empowerment8. This aligns with research showing that knowledge is a protective factor that enhances adherence and reduces stigma22,23. However, literacy alone cannot eliminate systemic barriers. For instance, a Black patient might fully understand the importance of adhering to antiretroviral therapy but lack transportation to clinics, face discrimination from healthcare providers, or fear disclosing their status within their community24. Therefore, empowerment through literacy must be combined with structural reforms, because without them a paradox arises: individuals become empowered with knowledge but remain powerless within systems that continue to exclude and oppress them.

The concept of stigma appears across all study themes, influencing disclosure, adherence, and psychosocial well-being. Stigma operates at multiple levels: individual (internalized shame and fear of rejection), interpersonal (discrimination by family, peers, and healthcare providers), and structural (policies and norms that reinforce exclusion). Earnshaw et al.'s25 stigma framework demonstrates how these levels intersect and weaken health outcomes. For ACB communities, stigma is intensified by racialisation, as HIV intersects with anti-Black racism, creating “intersectional stigma”16. The outcome is a cycle of secrecy, delayed testing, and poor adherence, which perpetuates transmission and worsens health outcomes.

The barriers faced by ACB individuals in HIV care go beyond personal tragedy; they reveal systemic failures that threaten public health. First, unequal access hampers the collective effort to end HIV as a public health threat by 203026. Canada cannot achieve sustained viral suppression nationwide if key subpopulations are excluded. Second, inequities worsen health disparities, opposing Sustainable Development Goal27. Third, ongoing racism in healthcare damages trust not only among ACB communities but across all marginalized groups, undermining the legitimacy of public health institutions.

The lived experiences of ACB individuals in Alberta demonstrate that HIV care inequalities are driven by structures rooted in racism, stigma, and systemic neglect rather than by chance. While biomedical advancements aim to eliminate HIV/AIDS as a public health threat, this can only be achieved if equity remains at the centre of policy and practice. Addressing the invisibility and lack of belonging of Black people in HIV care is not only a moral obligation but also a crucial public health issue. Ending HIV requires more than just medications and targets; it involves dismantling racism, fostering a sense of belonging, and building systems where all lives matter, are visible, valued, and supported. Anti-Black racism in HIV care must be eliminated; this is the only way to effectively address the ongoing public health crisis related to belonging.

References

  1. Graham T, Nyambi A, Barkhad A, et al, (2023). HIV and Black people in Canada: protocol for a scoping review. JMIR Research Protocols, 20(12), e49066. https://doi.org/10.2196/49066.
  2. Haddad N, Li JS, Tottenn S, & McGuire M. (2018). HIV in Canada: Surveillance report, 2017. Canadian Communicable Disease Report, 44(12), 348-356.
  3. Lawrence S, & Hylton K. (2022). Critical Race Theory, methodology, and semiotics. Cultural Studies, Critical Methodologies, 22(3), 255-265.  https://doi.org/10.1177/15327086221081829.
  4. Crenshaw K. (1991). Mapping the margins: Intersectionality, identity politics, and violence against women of colour. Stanford Law Review, 43(6), 1241-1299.
  5. Public Health Agency of Canada. (2022). Estimates of HIV incidence, prevalence, and Canada’s progress on meeting the 90–90–90 HIV targets, 2020. https://www.canada.ca/en/public-health/services/publications/diseases-conditions/estimates-hiv-incidence-prevalence-canada-meeting-90-90-90-targets-2020.html. Accessed 22 Oct 2024.
  6. Etowa J, Tharao W, Mbuagbaw L, et al, (2022). Community perspectives on addressing and responding to HIV-testing, pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) among African, Caribbean and Black (ACB) people in Ontario, Canada. BMC Public Health, 22, 913. https://doi.org/10.1186/s12889-022-13093-0.
  7. Ross J, Cunningham C, & Hanna D. (2018). HIV outcomes among migrants from low-income and middle-income countries living in high -income countries: A review of recent evidence. Current Opinion in Infectious Diseases, 31(1), 25-32.  https://doi.org/10.1097/QCO.0000000000000415.
  8. Osuji J, Domingo A. & Olokude F. (2025). Healthcare lived experiences of African, Caribbean, and Black individuals in Alberta living with HIV/AIDS: A phenomenological study. Can J Public Health 116, 184–193. https://doi.org/10.17269/s41997-024-00993-4.
  9. Husbands W, Lawson DO, Etowa EB, et al, (2022). Black Canadians’ exposure to everyday racism: Implications for health system access and health promotion among urban Black communities. Journal of Urban Health, 99(5), 829–841. https://doi.org/10.1007/s11524-022-00676-w.
  10. Razack S, & Hanson M. (2021). Time to dismantle systemic anti-Black racism in medicine in Canada. Canadian Medical Association Journal, 193(26), E1032–E1035.  https://doi.org/10.1503/cmaj.210675.
  11. Dryden OS, & Nnorom O. (2021). Time to dismantle systemic anti-Black racism in medicine in Canada. Canadian Medical Association Journal, 193(2), E55–E57.   https://doi.org/10.1503/cmaj.201579.
  12. Crenshaw KW. (1989). Demarginalizing the intersection of race and sex: A Black feminist critique of antidiscrimination doctrine, feminist theory and antiracist politics. University of Chicago Legal Forum, 1989(1), 139–167.
  13. Lawrence S, & Hylton K. (2022). Critical race theory, methodology, and semiotics: The analytical utility of a “race” conscious approach for visual qualitative research. Cultural Studies Critical Methodologies, 22(3), 255–265.
  14. Bauer GR, Churchill SM, MahendranM, et al, (2021). Intersectionality in quantitative research: A systematic review of its emergence and applications of theory and methods. SSM Population Health, 14, 100798.  https://doi.org/10.1016/j.ssmph.2021.100798.
  15. Kwarteng J, Coppolino PS, Farrell T, et al, (2022). Misogynoir: Challenges in detecting intersectional hate. Social Network Analysis and Mining, 12(1), 60.  https://doi.org/10.1007/s13278-022-00993-7.
  16. Logie CH, Williams CC, Wang Y, et al. (2019). Adapting stigma mechanism frameworks to explore complex pathways between intersectional stigma and HIV-related health outcomes among women living with HIV in Canada. Social Science & Medicine232, 129–138.  https://doi.org/10.1016/j.socscimed.2019.04.044.
  17. Haim-Litevsky D, Komemi R, & Lipskaya-Velikovsky L. (2023). Sense of belonging, meaningful daily life participation, and well-being: Integrated investigation. International Journal of Environmental Research and Public Health, 20(5), 4121.   https://doi.org/10.3390/ijerph20054121.
  18. Swenson RR, Rizzo CJ, Brown LK, et al, (2010). HIV knowledge and its contribution to sexual health behaviors of low-income African American adolescents. Journal of the National Medical Association, 102(12), 1173–1182. https://doi.org/10.1016/s0027-9684(15)30772-0
  19. Public Health Agency of Canada. (2020). Social determinants and inequalities in health for Black Canadians: A snapshot: https://www.canada.ca/content/dam/phac-aspc/documents/services/health-promotion/population-health/what-determines-health/social-determinants-inequities-black-canadians-snapshot/health-inequities-black-canadians.pdf. Accessed 22 Oct 2024.
  20. Statistics Canada. (2021). Black history month 2024….by the numbers. Retrieved from: https://www.statcan.gc.ca/en/dai/smr08/2024/smr08_278. Accessed 22 Oct 2024.
  21. Bailey ZD, Krieger N, Agénor M, et al, (2017). Structural racism and health inequities in the USA: Evidence and interventions. Lancet, 389(10077), 1453–1463.  https://doi.org/10.1016/S0140-6736(17)30569-X.
  22. Brown MJ, Serovich JM, Kimberly JA, & Hu J. (2016). Psychological reactance and HIV-related stigma among women living with HIV. AIDS Care28(6), 745–749. https://doi.org/10.1080/09540121.2016.1147015.
  23. Klein H, Sterk CE, & Elifson KW. (2016). Knowledge about HIV in a community sample of urban African Americans in the South. Journal AIDS Clinical Research, 7(10), 622. https://doi.org/10.4172/2155-6113.1000622.
  24. Djiadeu P, Yusuf A, Ongolo-Zogo C, et al, (2020). Barriers in accessing HIV care for Francophone African, Caribbean and Black people living with HIV in Canada: A scoping review. British Medical Journal Open, 2020(10), e036885. https://doi.org/10.1136/bmjopen-2020-036885.
  25. Earnshaw VA, Smith LR, Chaudoir SR, Amico, KR, & Copenhaver MM. (2013). HIV stigma mechanisms and wellbeing among PLWH: A test of the HIV stigma framework. AIDS and Behavior17(5), 1785–1795. https://doi.org/10.1007/s10461-013-0437-9.
  26. UNAIDS. (2014). 90-90-90: An ambitious treatment target to help  end the AIDS epidemic. Joint United Nations Programme on HIV/AIDS.
  27. UNDP. (2024). What are the sustainable development goals. Retrieved from:  https://www.undp.org/sustainable-development-goals. Accessed 22 Oct 2024.
 

Article Info

Article Notes

  • Published on: November 18, 2025

Keywords

  • African
  • Caribbean Black (ACB)
  • HIV
  • Health Equity
  • Racism
  • Stigma
  • Public Health

*Correspondence:

Joseph Osuji,
Professor and Director, School of Nursing and Midwifery, Mount Royal University, Calgary, Canada;
Email: josuji@mtroyal.ca

Copyright: ©2025 Osuji J. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License.